# Filing Detail

Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-25-071996
Filing Date
2025-05-15
Accepted
2025-05-15 07:41:51
Documents
67
Period of Report
2025-03-31

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | 10-Q | pyxs-20250331.htm iXBRL | 10-Q | 2038841
2 | EX-10.1 | pyxs-ex10_1.htm | EX-10.1 | 49022
3 | EX-31.1 | pyxs-ex31_1.htm | EX-31.1 | 16454
4 | EX-31.2 | pyxs-ex31_2.htm | EX-31.2 | 16436
5 | EX-32.1 | pyxs-ex32_1.htm | EX-32.1 | 9923
6 | EX-32.2 | pyxs-ex32_2.htm | EX-32.2 | 9191
7 | GRAPHIC | img33342731_0.jpg | GRAPHIC | 664529
| Complete submission text file | 0000950170-25-071996.txt |  | 9665916

Data Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
8 | XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT | pyxs-20250331.xsd | EX-101.SCH | 1355201
69 | EXTRACTED XBRL INSTANCE DOCUMENT | pyxs-20250331_htm.xml | XML | 1135851

Mailing Address 321 HARRISON AVENUE BOSTON MA 02118
Business Address 321 HARRISON AVENUE BOSTON MA 02118 (617) 221-9059
Pyxis Oncology, Inc. (Filer) CIK: 0001782223 (see all company filings)

EIN.: 831160910 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-40881 | Film No.: 25948744
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)